Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride

NDC 51316-015 · CVS Health Corp

Generic nameFexofenadine Hydrochloride and Pseudoephedrine Hydrochloride

Dosage formTABLET, EXTENDED RELEASE

RouteORAL

Active ingredient(s)FEXOFENADINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE

Strength60; 120 mg/1; mg/1

Pharmacologic classAdrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]

Marketing categoryANDA

Packages

51316-015-20 — 4 BLISTER PACK in 1 CARTON (51316-015-20) / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

51316-015-30 — 6 BLISTER PACK in 1 CARTON (51316-015-30) / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

50580-659 — Acetaminophen, Pseudoephedrine, 50580-719 — Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride, 50580-728 — Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride, 50844-112 — Pseudoephedrine HCl, 50991-142 — Dexbrompheniramine Maleate, Dextromethorphan Hydrobromide and Pseudoephedrine Hydrochloride, 50991-212 — Guaifenesin and Pseudoephedrine HCl, 50991-214 — Dextromethorphan HBr, Guaifenesin and Pseudoephedrine HCl, 50991-535 — ACETAMINOPHEN, DEXTROMETHORPHAN HBr, GUAIFENESIN, PSEUDOEPHEDRINE HCl, 50991-865 — Dexbrompheniramine Maleate, Pseudoephedrine HCL, 51316-007 — Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride, 51316-018 — Fexofenadine HCl and Pseudoephedrine HCl, 51316-121 — Pseudoephedrine HCl, 51316-183 — FEXOFENADINE HYDROCHLORIDE, 51316-260 — Fexofenadine HCl, 51316-317 — Pseudoephedrine Hydrochloride, 51316-339 — Naproxen sodium, Pseudoephedrine hydrochloride, 51316-345 — guaifenesin, pseudoephedrine hydrochloride, 51316-607 — Cetirizine hydrochloride, Pseudoephedrine hydrochloride, 51316-616 — Pseudoephedrine Hydrochloride, 51316-767 — Fexofenadine HCL, +483 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels